STERIS stock gets a strong-buy upgrade after 7.3 percent growth
Published on 10/04/2026 at 21:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
STERIS stock (ISIN IE00BFY8C754) was last at USD 208.54 on the NYSE on October 2, 2026, down 0.38 percent from the prior close. The latest analyst action came on October 3, when MarketBeat reported that Wall Street Zen raised its rating from Buy to Strong Buy.
Analyst target stays above USD 271
MarketBeat described the broader view as Moderate Buy, based on three Buy ratings and one Hold rating, with an average price target of USD 271.33. That target lies 30.1 percent above the October 2 price, creating a clear gap between the latest quotation and the published analyst average.
The same analyst review said UBS lowered its target from USD 275.00 to USD 270.00 on August 7, 2026, while Piper Sandler raised its target from USD 270.00 to USD 275.00 and retained an Overweight rating on the same date. The split matters because the bullish consensus coexists with different views on valuation.
Revenue growth supports fiscal guidance
STERIS generated USD 1.49 billion in fiscal 2027 first-quarter revenue for the period ended June 30, 2026, up 7.3 percent from the prior-year quarter, according to Zacks. Adjusted EPS was USD 2.59, up from USD 2.34 a year earlier and USD 0.10 above the cited consensus estimate.
The quarter also showed a mixed operating picture across the business. Healthcare revenue increased 7.6 percent to USD 1.05 billion, AST revenue rose 5.8 percent to USD 297.6 million, and Life Sciences revenue climbed 8.6 percent to USD 146.7 million, while the company maintained fiscal 2027 adjusted EPS guidance of USD 11.10 to USD 11.30, according to Zacks.
Stock remains below its yearly high
The USD 208.54 quotation sits between the NYSE 52-week low of USD 195.14 and high of USD 269.44. STERIS carried a market capitalization of USD 20.3 billion and volume of 675,312 shares on October 2, 2026, giving the analyst target and the latest earnings growth most of their market relevance.
STERIS stock holds at USD 208.54
STERIS stock was last at USD 208.54 on the NYSE on October 2, 2026, with a daily change of minus 0.38 percent; the company reported USD 2.59 in adjusted fiscal 2027 first-quarter EPS and USD 1.49 billion in revenue for the period ended June 30, 2026.
STERIS stock details
- Company: STERIS plc
- ISIN: IE00BFY8C754
- Ticker: STE
- Trading venue: NYSE
- Price (as of October 2, 2026, 4:00 p.m. ET): USD 208.54
- Market capitalization: USD 20.3 billion (as of October 2, 2026)
- 52-week range: USD 195.14-269.44 (as of October 2, 2026)
- Sector / Industry: Health Care
